Document Detail

Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy.
MedLine Citation:
PMID:  23146971     Owner:  NLM     Status:  Publisher    
Background:Organ confined prostate cancer (PCa) can be cured by radical retropubic prostatectomy (RRP); however, some tumors will still recur. Current tools fail to identify patients at risk of recurrence. Glutathione-S-transferases (GSTs) are involved in the metabolism of carcinogens, hormones and drugs. Thus, genetic polymorphisms that modify the GST activities may modify the risk of PCa recurrence.Methods:We retrospectively recruited Argentine PCa patients treated with RRP to study the association between GST polymorphisms and PCa biochemical relapse after RRP. We genotyped germline DNA in 105 patients for: GSTP1 c.313A>G (p.105 Ile>Val, rs1695) by PCR-RFLP; and GSTT1 null and GSTM1 null polymorphisms by multiplex PCR. Kaplan-Meier curves and Cox proportional hazard models were used to evaluate these associations.Results:Patients with GSTP1 c.313GG genotype showed shorter biochemical relapse-free survival (BRFS) (P=0.003) and higher risk for recurrence in unadjusted (Hazard ratio (HR)=3.16, 95% confidence interval (95% CI)=1.41-7.06, P=0.005) and multivariate models (HR=3.01, 95% CI=1.13-8.02, P=0.028). We did not find significant associations for GSTT1 and GSTM1 genotypes. In addition, we found shorter BRFS (P=0.010) and increased risk for recurrence for patients having two or more risk alleles when we combined the genotypes of the three GSTs in multivariate models (HR=3.06, 95% CI=1.20-7.80, P=0.019).Conclusions:Our results give support to the implementation of GSTs genotyping for personalized therapies as a novel alternative for PCa management for patients who undergo RRP. To the best of our knowledge, this is the first study that examined GST polymorphisms in PCa progression in Argentine men. Replication of our findings in larger cohort is warranted.Prostate Cancer and Prostatic Disease advance online publication, 13 November 2012; doi:10.1038/pcan.2012.45.
J Cotignola; D B Leonardi; A Shahabi; A D Acuña; M C Stern; N Navone; C Scorticati; A De Siervi; O Mazza; E Vazquez
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Prostate cancer and prostatic diseases     Volume:  -     ISSN:  1476-5608     ISO Abbreviation:  Prostate Cancer Prostatic Dis.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815755     Medline TA:  Prostate Cancer Prostatic Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Biological Chemistry, School of Sciences, University of Buenos Aires-IQUIBICEN, CONICET, Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients...
Next Document:  Second to fourth digit ratio and prostate cancer severity.